---
document_datetime: 2023-09-21 19:40:18
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/movymia-epar-all-authorised-presentations_en.pdf
document_name: movymia-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.8355296
conversion_datetime: 2025-12-30 02:34:59.410388
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength    | Pharmaceutical form    | Route of administration   | Immediate Packaging   | Content (concentration)   | Pack size             |
|------------------|-------------------|-------------|------------------------|---------------------------|-----------------------|---------------------------|-----------------------|
| EU/1/16/1161/001 | Movymia           | 20 µg/80 µl | Solution for injection | Subcutaneous use          | cartridge (glass)     | 2.4 ml                    | 1 cartridge           |
| EU/1/16/1161/002 | Movymia           | 20 µg/80 µl | Solution for injection | Subcutaneous use          | cartridge (glass)     | 2.4 ml                    | 3 cartridges          |
| EU/1/16/1161/003 | Movymia           | 20 µg/80 µl | Solution for injection | Subcutaneous use          | cartridge (glass)     | 2.4 ml                    | 1 cartridge and 1 pen |